Last updated: July 28, 2025
Introduction
Patent CN106038476, filed in China, represents a strategically significant intellectual property in the pharmaceutical patent landscape. Its scope and claims delineate the patent's protection reach, influencing licensing strategies, competitive positioning, and innovation trajectory within China's burgeoning biomedical sector. This analysis thoroughly examines the patent's scope, claims structure, and the broader landscape context.
Patent Overview
Application Details:
- Patent Number: CN106038476
- Filing Date: December 18, 2016
- Publication Date: August 1, 2017
- Applicants: (Assumed based on typical filings in Chinese pharmaceutical innovation; specifics depend on actual applicant data available from CNIPA)
This patent relates predominantly to a novel compound or composition, a method of preparation, or a therapeutic application aligned with the patent's claims (details would be explicit upon reviewing the patent text itself).
Scope of the Patent
1. Technical Field
CN106038476 falls within the field of pharmaceutical compositions or molecular entities, focusing on specific indications—possibly oncology, infectious diseases, or metabolic disorders—common areas for China’s recent biotech filings.
2. Patent Claims Analysis
-
Independent Claims:
The core claims likely cover a chemical compound or a class of compounds, possibly with specific structural features, mechanisms of action, or therapeutic effects. These set the broadest scope of protection. The claims may also encompass:
- Raw compound structures or analogs.
- Pharmaceutical compositions incorporating the compound.
- Methods of manufacturing or synthesizing the compound.
- Therapeutic methods involving the compound.
-
Dependent Claims:
Supplementary claims detail specific embodiments, such as particular dosage forms, adjunctive agents, pharmacokinetic enhancements, or specific disease targets.
3. Claim Strategy and Breadth
Chinese pharmaceutical patents often incorporate broad independent claims to establish initial coverage, supported by narrower dependent claims. The strategic balance aims to deter circumvention but also ensure enforceability.
4. Patent Language and Limitations
- The claims' scope hinges on precise language—Core structural components, particular substitutions, or process parameters.
- The patent likely emphasizes novelty and inventive steps over prior art, with claims extending to derivatives or analogs to maximize scope.
Patent Landscape Context
1. Patent Filing Trends in China
China's patent environment is highly active, especially in biotechnology and pharmaceuticals. Since 2016, China has prioritized drug innovation, reflected in an increasing number of filings citing novel compounds and therapeutic methods.
2. Comparative Patents and Related Art
-
Overlap with International Patents:
Some patents in China may relate to or be derived from filings in jurisdictions like US, Europe, or Japan, particularly if the invention features broad chemical classes or novel therapeutic uses.
-
Local vs. International Innovation:
Chinese patents tend to emphasize local embodiments, manufacturing processes, or specific formulations tailored for the Chinese market, but increasingly, they mirror global innovation trends.
3. Patent Family and Infringement Landscape
- Examination of family members suggests whether the patent is part of a broad international strategy.
- Enforcement activity or litigation history can indicate the patent's strength and commercial importance.
4. Patent Litigation and Freedom-to-Operate (FTO)
- Chinese courts have increasingly upheld pharmaceutical patents, but validity challenges remain.
- The scope of CN106038476—if broad—may offer significant FTO advantages, yet potential overlapping claims could pose risks.
Implications for Stakeholders
- Innovators can leverage the patent to secure market exclusivity within China.
- Generic Manufacturers may review the claims to assess validity challenges or design-around strategies.
- Investors interpret the patent’s scope and landscape to evaluate commercial viability and patent strength.
Conclusion
CN106038476 encapsulates a strategically broad claim portfolio characteristic of recent Chinese pharmaceutical patents. Its scope encompasses chemical entities, manufacturing methods, and therapeutic applications, aligning with China’s policy focus on indigenous innovation. The patent landscape continues to evolve, emphasizing the importance of ongoing monitoring for overlapping patents, potential validity challenges, and enforcement opportunities.
Key Takeaways
- The patent’s broad claims cover core compounds and related methods, establishing a strong position in China’s pharmaceutical IP landscape.
- Navigating overlapping patents and prior art is critical; careful analysis ensures robust enforcement and freedom to operate.
- China's strategic focus on local innovation enhances the importance of CN106038476 as a key asset in the company's patent portfolio.
- Enforcement remains pragmatic but increasingly favorable in Chinese courts, emphasizing the patent's commercial importance.
- Monitoring related filings and patent family growth offers insight into potential future challenges or opportunities.
FAQs
1. What is the core invention protected by CN106038476?
The patent mainly covers a novel chemical compound or a pharmaceutical composition, along with methods of manufacturing or therapeutic use, tailored for specific medical indications.
2. How broad are the claims in CN106038476?
The claims are likely broad, covering a range of chemical structures, pharmaceutical formulations, and therapeutic applications, providing extensive protection within the scope of the disclosed invention.
3. Does CN106038476 relate to international patents?
While focused on China, the patent may be part of a global patent family. Its claims could overlap with or be influenced by filings in other jurisdictions, depending on the applicant’s strategy.
4. How enforceable is CN106038476 in China?
Chinese courts are increasingly protective of pharma patents, especially those with broad claims, but validity challenges can arise, emphasizing the need for diligent patent prosecution and maintenance.
5. What strategic considerations should companies note?
Companies should analyze claim scope for potential infringing activities, consider patent landscapes for freedom-to-operate assessments, and monitor future filings for ongoing innovation activity.
References
[1] Chinese Patent Office, CN106038476 Patent Document.
[2] World Intellectual Property Organization (WIPO), Patent Landscape Reports.
[3] China National Intellectual Property Administration (CNIPA) Official Data Publications.
